Welcome to our dedicated page for Carter Bankshares SEC filings (Ticker: CARE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Carter Bankshares, Inc. (NASDAQ: CARE), the Virginia‑incorporated bank holding company for Carter Bank. Through these filings, investors can review the company’s formal disclosures on financial condition, capital, asset quality, risk factors and corporate actions.
Carter Bankshares, Inc. uses Form 8‑K to report material events, including quarterly and annual earnings releases, investor presentations, regulatory developments and other significant updates. For example, 8‑K filings reference press releases announcing financial results for periods such as the three and nine months ended September 30, 2025, as well as the year ended December 31, 2024. Other 8‑K filings furnish investor presentations dated as of quarter‑end and describe regulatory milestones, such as Carter Bank’s approval to become a state member bank of the Federal Reserve System.
Annual reports on Form 10‑K and quarterly reports on Form 10‑Q (accessible via the SEC’s EDGAR system) contain detailed information on loan and deposit portfolios, net interest income, noninterest income and expense, nonperforming loans, allowance for credit losses and the large credit relationship in the "Other" segment of the loan portfolio. These reports also include risk factor discussions and management’s analysis of the impact of nonaccrual loans related to the Justice Entities.
Investors can also review filings related to capital and governance, such as disclosures about stock repurchase programs, financial holding company status and regulatory oversight. Forms reporting executive or director share transactions (such as Form 4, when available) help track insider trading activity in CARE common stock.
Stock Titan’s platform enhances these filings with AI‑powered summaries that highlight key points from lengthy documents, explain technical terms and surface items such as changes in credit quality, capital ratios, branch transactions and regulatory developments. Real‑time updates from EDGAR ensure that new 10‑K, 10‑Q, 8‑K and other filings for Carter Bankshares, Inc. are available promptly, while AI insights help readers focus on the most important disclosures without manually parsing every page.
Carter Bankshares, Inc. furnished a Form 8-K to report that it has announced its financial results for the three and nine months ended September 30, 2025. The detailed numbers and commentary are provided in a press release attached as Exhibit 99.1, which contains the full third quarter 2025 financial results.
The filing also includes an extensive forward-looking statements disclaimer. It explains that future results can be affected by factors such as interest rates, credit quality, commercial real estate exposure, cybersecurity risks, economic conditions, regulatory actions and the outcomes of litigation. The company emphasizes that these statements are based on current assumptions and may differ materially from actual results, and it does not undertake to update them except as required by law.
Matthew M. Speare, SEVP and Chief Operating Officer of Carter Bankshares, Inc. (CARE), reported a sale of 13,550 shares of the issuer's common stock on 09/10/2025 at a reported price of $19.8341 per share. After the transaction, the reporting person beneficially owned 21,909 shares. The Form 4 was submitted by one reporting person and signed by an attorney-in-fact.
Wendy S. Bell, Senior Executive Vice President and Chief Financial Officer of Carter Bankshares, Inc. (CARE), reported transactions dated 08/26/2025. The filing shows a sale of 250 common shares at $19.54 per share. A separate entry records 100 shares transferred with a $0 price to Jessica Bell DiGiorgio, and an explanatory note states these shares no longer have pecuniary interest due to Jessica no longer being in the household and were disposed into Jessica Bell DiGiorgio’s name only. The form was signed by an attorney-in-fact.
Catharine L. Midkiff, a director of Carter Bankshares (CARE), reported a sale of 2,000 shares of common stock on 07/30/2025 at approximately $17.76 per share, leaving her with 16,054 shares beneficially owned. The filing notes that 200 of the sold shares matched a purchase on 06/02/2025, producing $258 in short-swing profits that the reporting person voluntarily disgorged to the issuer.
The explanation states the matched sale was inadvertently within six months of the earlier acquisition to the extent of 200 shares and that the reporting person has remedied the matter by returning the realized profits to the company. The Form 4 is signed by an attorney-in-fact.
Carter Bankshares disclosed that Chief Executive Officer Litz H. Van Dyke shared a letter with employees informing them of a recent medical update. The company furnished that letter as Exhibit 99.1 under a Regulation FD disclosure. The filing contains no financial metrics, operating details, transaction information, or statements about changes to leadership, succession plans, or business operations. The report is signed on the company’s behalf by Chief Financial Officer Wendy S. Bell. The 8-K therefore communicates the CEO’s employee-facing medical update without providing any information about material impacts to the company’s financial position or operations.
Carter Bankshares (CARE) director James W. Haskins reported an open-market sale of 2,000 common shares on 07/28/2025 at $17.84 each.
- Gross proceeds: ≈$35,680.
- Post-sale holdings: 61,900 shares held directly and 1,751 shares held indirectly through his spouse.
- No derivative securities were reported.
The filing signals a modest reduction in insider ownership but the director retains a sizeable stake, maintaining alignment with shareholders.